Newborn affected by maternal use of opiates

This code identifies a newborn diagnosed with a condition resulting from the mother's use of opiate drugs during pregnancy. This typically manifests as Neonatal Abstinence Syndrome (NAS) or other adverse effects directly attributable to in-utero opiate exposure.

Apply this code when a neonate exhibits signs or symptoms of withdrawal or other physiological effects due to maternal opiate use. Documentation should clearly state the mother's opiate use and the newborn's resulting condition, often confirmed by toxicology screens or clinical assessment.

• Always sequence this code as a secondary diagnosis, following the code for the specific condition (e.g., Neonatal Abstinence Syndrome, P96.1).
• Ensure documentation explicitly links the newborn's condition to maternal opiate use, not just a positive toxicology screen.
• Do not use this code if the mother's opiate use was for legitimate medical purposes and did not result in adverse effects in the newborn.